series-a
Stage
2022
Founded
4
Investors
About
Epoch Biodesign is a synthetic biology company that engineers enzymes using AI and robotic automation to convert hard-to-recycle plastics into valuable, low-carbon chemicals. Founded in 2019 by Jacob Nathan, the team is based in London.
Explore Epoch Biodesign's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.